What should I know first?
The term commonly refers to insufficient benefit from at least two adequately tried antidepressants. Clinicians review the dose, duration, adherence and diagnosisDiagnosisA clinical conclusion about the condition that best explains a person’s symptoms and other findings.Read the full definition of Diagnosis before concluding that a treatment has failed. Definitions and eligibility criteria differ across research, medicine licences and services.
Important Distinctions
Treatment resistance does not mean that recovery is impossible or that a person has failed. Options may include psychological treatment, changes to medicines, augmentation and brain stimulation. Eligibility for ketamine or esketamine requires a separate clinical assessment and country-specific information.
Sources and References
- Depression: treatment and brain stimulation options
- Spravato: current US prescribing information (revised March 2026)
- Spravato 28 mg nasal spray: UK Summary of Product Characteristics
Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.
Article Information
- Edition
- United Kingdom
- Content updated
- 2026-10-19
- Sources checked
- Listed with each reference above; retained dates for shared scientific content.
- Publication status
- Published

